Professional Documents
Culture Documents
10 1 1 487 543 PDF
10 1 1 487 543 PDF
Antiperspirants:
New Trendsin
FormulationandTestingTechnology
ERIC JUNGERMANN, Ph.D.*
PresentedDecember11, 1973,New York City
INTRODUCTION
621
622 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS
Active Ingredients
Aluminumchloridehas been recognizedfor many years as an excellent
antiperspirant.However, becauseof its low pH, it will causefabric damage
and skin irritation (6). This had led to the developmentof variousbasic
aluminumcompounds which are lessacidic than the parent product.The
mostfrequentlyused of thesederivativesis basicaluminumchlorhydroxide.
Other metal saltsthat havebeenformulatedinto antiperspirants are shownin
Table I. In addition to thesecompoundswhich are consideredto interfere
TRENDS IN ANTIPERSPIRANTS 623
Table I
Suspending
Oils
Someof the cosmetic oilsusedin powder-in-oil
formulations are listedin
TableII. They includeisopropylandpropy]eneglycolestersof variouslong-
Table II
Isopropyl myristate
Isopropylpalmirate
Mixed isopropylestersof variousfatty acids
Propy]eneglycol dicaprate
Propyleneglycol400 mono]aurate
Propyleneglycoldipelargonate
Triethyl citrate
Dibutyl phthalate
Organosilicones
624 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS
chainfatty acids,homopolymers
of polypropyleneoxide,dibutylphthalate,
Tween 60, and certainorganosilieones.
Propertiesof theseoilsincludelow
odor,low viscosity,andgoodstability.
SuspendingAgents
Suspending agentsare frequentlyusedin aerosolpowder-in-oil systems
wherethe activematerialis dispersed ratherthan dissolved. The suspending
agentsreducethe rate of settlingof the dispersed materials.
An effectivesuspending agentcommonly usedis Bentone34,* an organic
derivativeof hydrousmagnesium aluminum silicate.Bentone requiresbatch
heatingand extensive homogenization.Homogenization causesthe formation
of hydrogen bondsbetweensilicasites,resultingin latticeformation.
Anotherfrequentlyusedsuspending agentis Cab-O-Si],ta fire-dryfumed
silica.Chainsare formedvia hydrogenbonds,and with shearmixing,an
effectivelattice structurecan be created.Cab-O-Silis quite sensitiveto the
presenceand the ionicnatureof othermaterials
in the formulation.
Syloid
244*is anotherhigh-porosity
micron-sized
silicathat hasalsobeenused.
The typeof suspendingagentusedin antiperspirantpowderformulations
canbe readilyidentifiedfromX-ray diffractiondeterminations.
Propellants
The propellantsusedin aerosolantiperspirants serveseveralimportant
functions: they deliverthe product,serveas diluentsand/or solvents,
and
assistin product"drying."Generalfactorssuchas bounceand coldness are
directlyrelated.Thecoldersprays generally
produce lessbounce,andthisis
a functionof theboilingpointsof thevariouspropellants
used.Several
trade-
offs are frequentlynecessary in optimizingan antiperspirantpropellant
system.
POWDER-IN-OIL FORMULATIONS
Powder-in-oil
formulations
representthe mostimportantcategory of prod-
uctspresentlyon the market.This categorycontainsthreedifferenttypes:
regularpowder-in-oil
formulations,
theso-called aerosolpowders,andhybrid
formulations.
There are very noticeabledifferencesfrom the cosmeticand
aesthetic
pointof viewbetweenthesethreeproductforms.A typicalpowder-
in-oil formulationis the following:
Aerosolpowderformulations
containaboutthe samelevel of ingredientsas
powder-in-oilsversions,but in addition also contain 1% of talc. Also, the oil
levelis considerably
lower.A typicalformulais shownbelow:
Ingredient Per Cent
Table IV
EVALUATION PROCEDURES
Methods of Evaluation
We have testedtwo basicvariationsof the gravimetricmethod,the major
differencebeingin the procedureusedfor stimulationand collectionof per-
spiration.The first method,termed "normal activity method,"utilizes normal
environment conditions. The second method, termed "controlled environ-
ment method,"employsthermallycontrolledenvironmentalconditions.In
both methods,a ratio of sweatproducedby the left and right axilla is de-
terminedin a seriesof controlledcollections.The effectof antiperspirantma-
terialson the perspirationrate of eachindividualis determinedby comparing
the post-treatmentratio to the subjects'averagecontrolratio. For each indi-
vidual,the per centchangein sweatrate is calculatedas:
%change
insweat
rate
= 100
(1- post-treatment
average ratio
control
ratio
)
These data are statisticallytreated by applyingthe Studentt distribution
to establish85%confidence limitson the meanper centchangein sweatratio.
DeodorantEJficacyEvaluation
Deodoranteffectiveness is a recognizedattribute of many metal salts
(35-37). Efficacyis evaluated
by comparisonof the effectof onetreatmentin
one axilla versus a second treatment in the other axilla of the individuals in
panel groups(34, 38). Similarcomparativemethodsmay employa crossover
procedure.Productcomparisons usinga split axilla treatmentwithout cross-
overin a singlegroupsufferin reliabilitybecauseodorintensityof the axillae
of an individualvaries.However,when the test sitesin a panel are random-
izedby a crossover
procedure,
effectsdueto inherentdifferences
in the axil-
lae are minimized.
Axillary odor may be judged by the panel participantsthemselves,by
trainedjudges,or both.Lengthof deodoranteffectis usuallydeterminedat
variousintervalsduring the test, or at cessationto treatment.Evaluation may
bc madeby estimatingthe degreeof odorof both the axilhe and the under-
garmentat the sideof contact.Odor judgmentsobtainedare usuallybased
uponarbitrarynumericalscales(38-40). Becausetheseare subjectiveevalu-
ations,severalinvestigatorshave attemptedto eliminatesourcesof error
throughthe useof osmometers (41).
Utilizing a crossovermethod in which odor evaluatiouswere made by
trainedjudges,a cleardeodoranteffectwasshownfor a powdertin-oilformu-
lation and an aerosolpowder formulation,both containing3.5% alnminum
chlorhydroxide.An odorscaleof i (little or no odor) to 5 (strongor disagree-
able odor) wasused.The resultsare shownin Table V. The data from the test
andcontrolperiodsweresubiected to Student'st testandwerehighlysignifi-
cant.
Staining Potential
Soonafter the introductionof aerosolantiperspirants,it becameapparent
that fabricstainingin the axillaryareawasa majorproblem.Initially, formu-
lationswere testedfor stainingpropensityby applyingthe productdirectlyto
the fabric.It wasfoundthat thiswasnot a satisfactoryproceduresinceit did
notreflectactualuseconditions anda comparative
procedure wasdeveloped.
In thisprocedure,a panelis usedmadeup of 10 •nenand 10 women.Sub-
jectsare required to abstainfrownthe use of all antiperspirantsand deodor-
antsor otherproductsappliedto the axillaryarea, and are requiredto use
630 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS
Table V
amber-blue •
x 10
green
Table VI
StainingPropensityof AerosolAntiperspirantFormulations
(Three-Day Test Period)
Formulation Formulation
(Active/Oil) Type StainingValue
5% aluminumhydroxychloride- Hybrid 1.0
zirconyl hydroxychloride-
glycinecomplex/dibutylphthalate
3.5% aluminum½hlorhydrate
/ mixed Aerosol 0.17
silicones powder
CosmeticAcceptability
In consideringthe overallpropertiesof an antiperspirant, cosmeticand
perfumequalitiesare a key consideration. The dispensing oils,when not
runny,cancreatea pleasant tactilefeel.The propellant, whenoptimized, can
reducecoldness of the spraywhenappliedto the skin.Overall,a productis
cosmetically
betterwhenit goesondry,withoutcaking, andis gentleto both
skin and clothing.The besttechniquefor evaluatingthesepropertiesand
theiroveralleffecton productacceptability is by full scalemarketresearch
procedures,thoughsomelaboratory procedures for individualpropertiesare
also used.
632 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS
Safety
The criteria for evaluatingsafety of antiperspirantformulationsinclude
a consideration of the effect of the product on the skin and its aerosolized
properties.Routinesafetyevaluationof a new formulationcomprisesdeter-
minationof acute oral and dermal toxicity,primary eye and skin irritation,
acute and subacuteinhalationstudiesin rabbits and monkeys,and sensitiza-
tion in guineapigsand in humans.
Aerosolantiperspirants have receivedconsiderable publicity as a resultof
potentialinhalationhazardsthat may be associated with low-level,long-term
exposureto propellantgasesand particulateaerosolsin general.Recently,
Drew (44) reportedthat persistentlung granulomas were observedin ham-
stersexposedto an aerosolized liquid systembasedon a propyleneglycol
complexof ACH at 50 mg/ma for 6 hoursa day for 10, 20, and 30 days.
Antiperspirantsare classified
asdrugsand are subjectto the Food and Drug
Administration's OTC review procedure.A requestto provide safety and
efficacydatafor reviewby the OTC panelhasbeenmade (45) and heatings
startedin the earlypart of 1974.
NominalActivity Method
The resultobtainedwhentestinga standardpowder-in-oilfor•nulationon
four differentoccasions
spreadovera periodof a year and a half are shown
in Table VII. The resultsare 3-day averagesand are expressed
with a con-
fidence limit of 95%.
Table VII
œ0.6 ___1.8
21.6 4- œ.6
œ1.0 4- œ.4
27.8 ___œ.7
TRENDS IN ANTIPERSPIRANTS 633
Table VIII
Aluminum
chlorhydroxide• 3.5 22.8 ñ 2.7
Basic aluminum bromide 3.5 23.6 + 4.0
Basic a]uminmn nitrate 3.5 23.2 + 3.9
Basic aluminum bromide- 3.5 25.5 ñ 4.0
zirconylhydroxyoxy-
bromide
Basicaluminum hydroxy 3.5 25.1 ___3.1
chloride-zirconylhydroxy
oxychloride
Magnesium aluminum zirconium 3.5 22.4 +__4.0
gluconatechloride
Magnesium aluminum zirconium 3.5 22.7 ñ 2.9
gluconatebromide
Table IX
AntiperspirantEfficacyof Different
FormulationTypes(Normal Activity Method)
Product Category Mean % Sweat Reduction
Table X
Table XI
Table XII
Table XIII
1 12.6ñ 3.6
2 33.6 _ 5.2
3 16.0 _ 4.1
4 22.3 _ 9.8
Table XIV
1 35.0 _ 4.2
2 6.7 _ 6.0
3 21.2 ñ 4.2
DISCUSSION OF RESULTS
Certainadditionalconsiderations
mustbe kept in mind when considering
gravimetricproceduresfor the determinationof antiperspirantefficacy.
Bakiewicz(48) has shownthat when thermal stimulationis usedto induce
perspiration,resultscan vary with body position.Resultscan also be influ-
encedby drinkingcold liquids,variationsin the relativehumidityof the
room,or even by selectingpanelistswho are "high sweaters"or "low sweat-
ers."For example,Tronn•erandRentschler
(47) reportedthat the sameprod-
uct under controlledenvironmentalconditionsgave a 9•0%sweat reduction
whenappliedto a lowsweater,
whiletherewasa 50%reduction
with a group
of peopleclassified
ashigh sweaters.
To summarizeour viewson antiperspiranttest methodology:regardless of
the methodsusedby us or reportedin the literature,mostof our resultsfor
TRENDS IN ANTIPERSPIRANTS 637
sweatreductionettlcacies
for aerosolpowder-in-oiland hybrid formulasfall
between20%to 30%.Thesefigurescanbe restatedby sayingthat a subject
was sweating with a 70% to 80% ettlciencyrather than his normal 100%
ettlciency.Thus, evenif laboratoryprocedures knowhow to measurethese
differences,it is debatablewhetherthe consumercan distinguishbetween
them. While not negatingthe use of thesegravimetricmethodsto provide
data to useas a guideto optimizeformulations, or to coinparenew active
ingredients,or to evaluateinteractionof materials,care must be taken.when
thesenumbersare used for promotionalpurposes.Sinall differences,even
thoughstatisticallysignificant,
shouldnot be magnifiedout of proportion.It
is importantthat management understandsand appreciatesthe differencesin
testinginethods,and recognizesthe limitationsand specializedmeaningof
the data derivedfrom thesetechniques.
(ReceivedApril 2, 1974)
REFERENCES
(1) Klarmann, E.G., The cosmetic aspects of perspiration and its control, Amer.
Per•um. Essent.Oil Rev., 52, 33-40 (1948).
(2) Salfield,H., The mechanismof perspiration,Ibid., 53, 385-7 (1949).
(3) deNavarre,M. G., The Chemistryand Manufactureof Cosmetics,2, D. Van Nostrand•
Princeton, N.J. 1962.
(4) Deodorantssprayingup a storm,Progressive Grocer,52 (8), 144-6 (1973).
(5) Reheis,Soonaerosolantiperspirants will dominatemarket,Drug Trade News (March
10, 1969).
(6) Bein, R. R., The action of antiperspirantcreamson fabrics,Proc. Sci. Sec. Toilet
GoodsAss., 4, 8 (1945).
(7) Papa, C. M., and Kligman, A.M., Mechanismsof eccrine anhydrosis.II. The
antiperspiranteffectof aluminumsalts,J. Invest. Dermatol.,49, 139 (1967).
(8) Parma,C. M., The action of antiperspirants,J. $oc. Cosmet. Chem., 17, 789-800
(1966).
(9) BritishPatent940,279(1963).
(lO) Helton, E.G., Daley, E. W., anti Erwin, J. C., Zirconlureoxychlorideantiperspirant,
Drug Cosmet.Ind., 80, 170 (1957).
(11) Grad, M., U.S. Patent2,854,382to Procterand Gamble(1958).
(12) Beckman,S. M., U.S. Patent 2,906,668 to Reheis Chemical (1959).
(13) Daley, E. W., U.S. Patent 2,814,584 to Procterand Gamble (1957).
(14) Daley, E. W., U.S. Patent 2,814,585 to Procter and Gamble (1957).
(15) Wainer, E., U.S. Patent 2,507,128 to National Lead (1950).
(16) Grote,I..W, U.S. Patent3,009,860to Chattanooga Medicine(1961).
(•7) GivaudanCorp., private communication(1973).
(18) Minor, V., Eines neues Verfahren zu der klinischen Untersuchung der Schweissa-
banderung,Deut. Z. Nervenh, 101, 302 (1927).
(19) Reller, H. H., Factors affecting auxfilary sweating,J. Soc..Cosmet. Chem., 15,
99-110 (1964).
(20) Zaheisky, •., and Rovensky,•., A comparisonof the effectivenessof several exter-
nal antiperspirants,
Ibid., 23, 775-89 (1972).
(21) Govett, T., deNavarre, M. G., Aluminum chlorhydrate: a new antiperspirant in-
gredient,Amer. Perpum.,49, 365 (1947).
(22) Ukrami, C., and Christian,J. E., An evaluationof the effectiveness
of antiperspi-
rant preparationsusing frog membraneand radioactivetracer techniques,J. Amer.
Pharm.Ass.,Sci. Ed., 42, 179 (1953).
638 JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS